Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Allograft rejection | R-HSA-9679028 | map05330 | meclozine | 4034 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | meclozine | 4034 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | naringin | 7741 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | naringin | 7741 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | naringin | 7741 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | naringin | 7741 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | naringin | 7741 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | naringin | 7741 | drug-path |
Circadian rhythm - mammal | R-HSA-400253 | 0 | naringin | 7741 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | naringin | 7741 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | naringin | 7741 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | naringin | 7741 | drug-path |
Asthma | R-HSA-444620 | map05310 | naringin | 7741 | drug-path |
Non-small cell lung cancer | R-HSA-5619066 | map05223 | naringin | 7741 | drug-path |
Gap junction | R-HSA-190861 | map04540 | naringin | 7741 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | naringin | 7741 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | naringin | 7741 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | naringin | 7741 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | naproxen | 156391 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | naproxen | 156391 | drug-path |